BDBM50099766 1-(4-Carbamoyl-2-{[1-(4-carbamoyl-2-{4-carbamoyl-2-[(9,10-dioxo-9,10-dihydro-phenanthrene-3-carbonyl)-amino]-butyrylamino}-butyryl)-pyrrolidine-2-carbonyl]-amino}-butyryl)-pyrrolidine-2-carboxylic acid::CHEMBL299209
SMILES NC(=O)CCC(NC(=O)c1ccc2C(=O)C(=O)c3ccccc3-c2c1)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O
InChI Key InChIKey=KPHNPJFWMNUZRV-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 50099766
TargetReceptor-type tyrosine-protein phosphatase C(Homo sapiens (Human))
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Astrazeneca Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 700nMAssay Description:In vitro inhibitory activity against the cytosolic portion of CD45 protein-tyrosine phosphatase using pNPP as the substrateMore data for this Ligand-Target Pair